In this issue:
– CV management of patients undergoing HSCT
– Performance and quality measures: Valvular and structural heart disease
– Wearable biosensors for CHD
– Exercise therapy for chronic symptomatic PAD
– Quality measures: Adults undergoing TAVI
– Clinical genetic testing for AF
– PBS update: Hypercholesterolaemia
– PI updates: Diltiazem hydrochloride
– PI updates: Gadobutrol
– New AusPAR: Enoxaparin sodium
– TGA safety advisory: Withania somnifera
– Heart Foundation’s food and nutrition position statements
– ATAGI advice on seasonal influenza vaccines in 2024
– ACHD Workforce Global Survey
– COVID-19 resources
– Conferences, workshops and CPD